News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AB Science (AB.PA) Publication of Preclinical Results Demonstrates That masitinib Can Act as a Potentiator of Chemotherapies


2/22/2011 11:00:58 AM

PARIS--(BUSINESS WIRE)--Regulatory News: AB Science SA (Paris:AB) (NYSE-Euronext - FR0010557264 - AB), a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors (PKIs), announces publication in The Veterinary Journal of results from a preclinical study showing that masitinib has potential as a chemosensitizer.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES